Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC24H22F3N5O5S |
InChIKeyXBILASWQSBQTIV-KRWDZBQOSA-N |
CAS Registry1092522-46-7 |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Neoplasms | Preclinical | United States | 01 Apr 2011 |





